Minimally invasive smart patches can continuously monitor glucose blood levels and administer insulin as needed.
Keeping immune cells in check to ward off diabetes
Bioengineered pancreatic beta cells adorned with immune checkpoint proteins prevent the progression of type 1 diabetes.
Artificial intelligence could be promising alternative to animal models
Replacing animal testing with the ever-growing capabilities of AI and deep learning could help minimize the need for animals in scientific discovery.
How do you sample blood in a non-invasive way?
Graphene-based biosensors incorporated in arrays of microneedles are emerging as an alternative to hypodermic needles and could be the next generation of blood sampling devices.
The challenges in moving beyond animal models in research
Animal testing remains a principle screening tool in the drug discovery pipeline, but are they reliable and could there be alternatives to replace them?
Earlier diagnosis and better treatment for type 1 diabetes
Nanotechnology is poised to revolutionize the diagnosis and treatment of patients with type 1 diabetes.
Developing artificial enzymes using computers
Artificial enzymes promise to not only help us understand the complex functioning of enzymes, but will create a new generation of biosystems for sustainable chemistry practices.
A nanoporous self-assembling network
Scientists have functionalized a simple nano-building block to form self-assembling molecular networks that exhibit exceptional properties.
Pioneers in Science: Sir Frederick Banting
A doctor and researcher, Banting pioneered the development of insulin for the treatment of diabetes.
The Promise of Cyborganic Beings
In this essay, scientists from Spain and Denmark delve into the spectrum of possibilities offered by wearable and implantable healthcare devices and provide new insight into the cyborganic era.